Elevated serum β-glucuronidase reflects hepatic lysosomal fragility following toxic liver injury in rats
Author:
- 1 April 2008
- journal article
- Published by Canadian Science Publishing in Biochemistry and Cell Biology
- Vol. 86 (3) , 235-243
Abstract
The level of serum β-glucuronidase increases in various pathological conditions, including liver disorders. The aim of this investigation was to study the changes in liver lysosomal membrane stability during experimentally induced hepatic fibrosis that may result in the elevation of serum β-glucuronidase. Liver injury was induced by intraperitoneal injections of N-nitrosodimethylamine (NDMA) in adult male albino rats over 3 weeks. The progression of fibrosis was evaluated histopathologically as well as by monitoring liver collagen content. Lipid peroxides and β-glucuronidase levels were measured in the liver homogenate and subcellular fractions on days 0, 7, 14, and 21 after the start of NDMA administration. Serum β-glucuronidase levels were also determined. A significant increase was observed in β-glucuronidase levels in the serum, liver homogenate, and subcellular fractions, but not in the nuclear fraction on days 7, 14, and 21 after the start of NDMA administration. Lipid peroxides also increased in the liver homogenate and the lysosomal fraction. The measurement of lysosomal membrane stability revealed a maximum lysosomal fragility on day 21 during NDMA-induced fibrosis. In vitro studies showed that NDMA has no significant effect on liver lysosomal membrane permeability. The results of this investigation demonstrated that lysosomal fragility increases during NDMA-induced hepatic fibrosis, which could be attributed to increased lipid peroxidation of lysosomal membrane. In this study, we also elucidated the mechanism of increased β-glucuronidase and other lysosomal glycohydrolases in the serum during hepatic fibrosis.Keywords
This publication has 34 references indexed in Scilit:
- siRNA-mediated knockdown of connective tissue growth factor prevents N-nitrosodimethylamine-induced hepatic fibrosis in ratsGene Therapy, 2007
- Mineral metabolism in dimethylnitrosamine-induced hepatic fibrosisClinical Biochemistry, 2006
- Serum hyaluronan and hyaluronidase: very early markers of toxic liver injuryClinica Chimica Acta, 2004
- Lactate Dehydrogenase Isoenzymes in Dimethylnitrosamine-Induced Hepatic Fibrosis in Rats.Journal of Clinical Biochemistry and Nutrition, 1997
- Glycoprotein metabolism in dimethyinitrosan ne induced hepatic fibrosis in ratsThe International Journal of Biochemistry & Cell Biology, 1996
- Molecular characteristics of dimethylnitrosamine induced fibrotic liver collagenBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1996
- Source of Increased Serum Beta-Hexosaminidase in Rat Liver CirrhosisEnzyme, 1988
- Tissue Content and Localization of Lysosomal Enzymes in Cholestatic RatsScandinavian Journal of Gastroenterology, 1986
- A dimethylnitrosamine-induced model of cirrhosis and portal hypertension in the ratJournal of Hepatology, 1985
- Regulation of lysosomal enzyme secretion: Role in inflammationInflammation Research, 1974